FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:141-144 January 14, 1999 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Educating the public about the risk of breast cancer promises to contribute to the prevention or early detection of the disease. Data on the risk of breast cancer are widely available to physicians and the public. However, for this information to be interpretable, it should be presented in a form that enables the risk to be understood in context. This is rarely the case, because of the difficulties involved in conveying such inherently complex information to a population and to individual women.

Several studies have shown that women tend to overestimate their risk of breast cancer and that many fail . . . [Full Text of this Article]

Address reprint requests to Dr. Phillips at the Department of Medical Oncology and Hematology, Peter MacCallum Cancer Institute, Locked Bag 1, A'Becket St., Melbourne 3000, Victoria, Australia.

References

Related Letters:

The One-In-Nine Risk of Breast Cancer
Harrell B. B., Phillips K.-A., Glendon G., Knight J.
Extract | Full Text  
N Engl J Med 1999; 340:1839-1840, Jun 10, 1999. Correspondence

This article has been cited by other articles:

• Narayan, K.M.V., Boyle, J. P., Thompson, T. J., Gregg, E. W., Williamson, D. F. (2007). Effect of BMI on Lifetime Risk for Diabetes in the U.S.. Diabetes Care 30: 1562-1566 [Abstract] [Full Text]  
• Vasan, R. S., Pencina, M. J., Cobain, M., Freiberg, M. S., D'Agostino, R. B. (2005). Estimated Risks for Developing Obesity in the Framingham Heart Study. ANN INTERN MED 143: 473-480 [Abstract] [Full Text]  
• Colleoni, M., Gelber, S., Goldhirsch, A. (2005). Treatment of advanced breast cancer: the good, the bad and the ugly. Ann Oncol 16: 1219-1221 [Full Text]  
• Yabroff, K R., Mandelblatt, J. S, Ingham, J. (2004). The quality of medical care at the end-of-life in the USA: existing barriers and examples of process and outcome measures. Palliat Med 18: 202-216 [Abstract]  
• Narayan, K. M. V., Boyle, J. P., Thompson, T. J., Sorensen, S. W., Williamson, D. F. (2003). Lifetime Risk for Diabetes Mellitus in the United States. JAMA 290: 1884-1890 [Abstract] [Full Text]  
• Thorstenson, Y. R., Roxas, A., Kroiss, R., Jenkins, M. A., Yu, K. M., Bachrich, T., Muhr, D., Wayne, T. L., Chu, G., Davis, R. W., Wagner, T. M. U., Oefner, P. J. (2003). Contributions of ATM Mutations to Familial Breast and Ovarian Cancer. Cancer Res. 63: 3325-3333 [Abstract] [Full Text]  
• Jacobsen, B. K., Heuch, I., Kvale, G. (2003). Age at Natural Menopause and All-Cause Mortality: A 37-Year Follow-up of 19,731 Norwegian Women. Am J Epidemiol 157: 923-929 [Abstract] [Full Text]  
• Love, R. R. (2002). Breast Cancer Prevention. The Oncologist 7: 100-102 [Full Text]  
• Vasan, R. S., Beiser, A., Seshadri, S., Larson, M. G., Kannel, W. B., D'Agostino, R. B., Levy, D. (2002). Residual Lifetime Risk for Developing Hypertension in Middle-aged Women and Men: The Framingham Heart Study. JAMA 287: 1003-1010 [Abstract] [Full Text]  
• Murphy, D. J., Gahm, G. J., Santilli, S., North, P., Oliver, S. C.N., Shapiro, H. (2002). Seniors' Preferences for Cancer Screening and Medication Use Based on Absolute Risk Reduction. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 57: M100-105 [Abstract] [Full Text]  
• Hershman, D., Sundararajan, V., Jacobson, J. S., Heitjan, D. F., Neugut, A. I., Grann, V. R. (2002). Outcomes of Tamoxifen Chemoprevention for Breast Cancer in Very High-Risk Women: A Cost-Effectiveness Analysis. JCO 20: 9-16 [Abstract] [Full Text]  
• Bastian, L. A., Lipkus, I. M., Kuchibhatla, M. N., Weng, H. H., Halabi, S., Ryan, P. D., Skinner, C. S., Rimer, B. K. (2001). Women's Interest in Chemoprevention for Breast Cancer. Arch Intern Med 161: 1639-1644 [Abstract] [Full Text]  
• Satagopan, J. M., Offit, K., Foulkes, W., Robson, M. E., Wacholder, S., Eng, C. M., Karp, S. E., Begg, C. B. (2001). The Lifetime Risks of Breast Cancer in Ashkenazi Jewish Carriers of BRCA1 and BRCA2 Mutations. Cancer Epidemiol. Biomarkers Prev. 10: 467-473 [Abstract] [Full Text]  
• Silverman, E., Woloshin, S., Schwartz, L. M., Byram, S. J., Welch, H. G., Fischhoff, B. (2001). Women's Views on Breast Cancer Risk and Screening Mammography: A Qualitative Interview Study. Med Decis Making 21: 231-240 [Abstract]  
• Berlin, L. (2001). Dot Size, Lead Time, Fallibility, and Impact on Survival: Continuing Controversies in Mammography. Am. J. Roentgenol. 176: 1123-1130 [Full Text]  
• Taylor, M R G (2001). Genetic testing for inherited breast and ovarian cancer syndromes: important concepts for the primary care physician. Postgrad. Med. J. 77: 11-15 [Abstract] [Full Text]  
• Woloshin, S., Schwartz, L. M., Byram, S., Fischhoff, B., Welch, H. G. (2000). A New Scale for Assessing Perceptions of Chance: A Validation Study. Med Decis Making 20: 298-307 [Abstract]  
• Lippman, S. M., Brown, P. H. (1999). Tamoxifen Prevention of Breast Cancer: an Instance of the Fingerpost. JNCI J Natl Cancer Inst 91: 1809-1819 [Full Text]  
• Love, R. R. (1999). Re: Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. JNCI J Natl Cancer Inst 91: 1891-1891 [Full Text]  
• Harrell, B. B., Phillips, K.-A., Glendon, G., Knight, J. (1999). The One-In-Nine Risk of Breast Cancer. NEJM 340: 1839-1840 [Full Text]  
• Chlebowski, R. T., Collyar, D. E., Somerfield, M. R., Pfister, D. G. (1999). American Society of Clinical Oncology Technology Assessment on Breast Cancer Risk Reduction Strategies: Tamoxifen and Raloxifene. JCO 17: 1939-1939 [Abstract] [Full Text]